Hodgkin Lymphoma
News
Cancer survival tied to reduction in treatment
Photo by Bill Branson Results of a large study suggest that long-term survivors of childhood cancer are living longer, partly due to a reduction...
News
Hodgkin lymphoma going untreated in patients with HIV
cultured lymphocyte Image courtesy of the CDC Patients with HIV-associated Hodgkin lymphoma may not be getting potentially curative treatment,...
News
Pregnancy did not increase Hodgkin lymphoma relapse rate
Key clinical point: Pregnancy did not increase the risk of relapse of Hodgkin lymphoma in a population-based study.
News
Medical Roundtable: Pediatric Non-Hodgkin Lymphoma (NHL) Classification Guidelines - International Pediatric NHL Staging System (IPNHLSS)
News
Long-term risk of hospitalization in cancer survivors
patient and her father Photo by Rhoda Baer Results of a large study suggest that adolescent and young adult cancer survivors have an increased...
News
Group quantifies cardiotoxicity risk with HL treatment
Photo by Rhoda Baer European researchers say they have quantified the risk of cardiovascular disease associated with treatments for Hodgkin...
News
ESRD treatments linked to different cancers
Photo by Anna Frodesiak Patients with end-stage renal disease (ESRD) may have different cancer risks according to the treatment they are...
News
Inhibitor exhibits ‘modest’ activity in lymphoma
A small-molecule inhibitor has shown modest anticancer activity in a phase 1 trial of patients with relapsed/refractory lymphoma or multiple...
News
CCSs have increased risk of autoimmune diseases
Photo by Bill Branson Childhood cancer survivors (CCSs) have an increased risk of developing autoimmune diseases, according to research published...
Conference Coverage
Reprogramming the immune system
showing Hodgkin lymphoma NEW YORK—Using a 3-pronged approach to reprogram the immune system—inhibition of critical pathways, activation of others...
News
Radioimmunotherapy shows promise for HL
Results of a small trial suggest the radiolabeled anti-CD25 antibody 90Y-daclizumab can treat certain patients with relapsed/refractory Hodgkin...